Single agent high-dose cisplatin (200 mg m-2) treatment in ovarian carcinoma.

Twenty patients with epithelial ovarian carcinoma were treated with high-dose cisplatin 200mg m-2. Patients were to receive three cycles at 21 day intervals. Treatment was stopped if severe myelosuppression or any neurotoxicity occurred. Overall, eight (40%) of patients responded with a complete res...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kehoe, S., Redman, C., Varma, R., Buxton, J., Luesley, D., Blackledge, G., Stanley, A.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1992
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1977413/
https://ncbi.nlm.nih.gov/pubmed/1419613
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars